These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21606612)

  • 1. Salmonella typhimurium harboring plasmid expressing interleukin-12 induced attenuation of infection and protective immune responses.
    Yoon WS; Choi HJ; Park YK
    J Gen Appl Microbiol; 2011; 57(2):115-22. PubMed ID: 21606612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
    Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
    BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective mucosal live attenuated Salmonella vaccine by deleting phosphotransferase system component genes ptsI and crr.
    Zhi Y; Lin SM; Jang AY; Ahn KB; Ji HJ; Guo HC; Lim S; Seo HS
    J Microbiol; 2019 Jan; 57(1):64-73. PubMed ID: 30552632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
    Piao HH; Tam VT; Na HS; Kim HJ; Ryu PY; Kim SY; Rhee JH; Choy HE; Kim SW; Hong Y
    J Microbiol; 2010 Aug; 48(4):486-95. PubMed ID: 20799091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization.
    Kang HY; Curtiss R
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):99-104. PubMed ID: 12832112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.
    Pathangey L; Kohler JJ; Isoda R; Brown TA
    Vaccine; 2009 May; 27(20):2707-11. PubMed ID: 19428883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.
    Hur J; Lee JH
    Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis.
    Datey A; Shreenivas M; Chandrasekharan G; Joseph J; Sah S; Aluri S; Saha S; Varshney U; Chakravortty D
    Vaccine; 2018 Nov; 36(50):7715-7727. PubMed ID: 30385055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice.
    Al-Ojali SM; Tara Moore CB; Fernandez-Cabezudo MJ; Al-Ramadi BK
    Med Microbiol Immunol; 2013 Feb; 202(1):49-61. PubMed ID: 22684724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine.
    Selke M; Meens J; Springer S; Frank R; Gerlach GF
    Infect Immun; 2007 May; 75(5):2476-83. PubMed ID: 17296750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity.
    Seo KY; Han SJ; Cha HR; Seo SU; Song JH; Chung SH; Kweon MN
    J Immunol; 2010 Sep; 185(6):3610-9. PubMed ID: 20709955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.
    Higginson EE; Ramachandran G; Panda A; Shipley ST; Kriel EH; DeTolla LJ; Lipsky M; Perkins DJ; Salerno-Goncalves R; Sztein MB; Pasetti MF; Levine MM; Tennant SM
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletions in
    Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
    Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.